7.3K
Downloads
58
Episodes
Welcome to Exhale, a podcast series discussing topical information about spirometry and respiratory care. Your host is Mark Russell, Marketing Communications Manager for Vitalograph US, a global leader in respiratory diagnostics.
Episodes
Wednesday Jul 19, 2023
Wednesday Jul 19, 2023
Annaka Haynes is a nursing student who has had Cystic Fibrosis since she was 6 weeks old. Trikafta developed by Vertex Pharmaceuticals was first approved by the FDA on October 21, 2019. This treatment is a triple combination regimen for cystic fibrosis patients starting at ages 2 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive to Trikafta based on in vitro data.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.